FTXH First Trust Nasdaq Pharmaceuticals ETF
Nasdaq US Smart Pharmaceuticals TR USD

NAV as of 25-Nov-2022

27.5205

4 Week: 26.39 - 27.48

52 Week: 23.96 - 28.10

Latest Closing Price

27.46

Premium / Discount

-0.19

Expense Ratio

0.6%

Investment Objective

The investment seeks investment results that correspond generally to the price and yield (before the fund's fees and expenses) of the Nasdaq US Smart Pharmaceuticals IndexTM. The fund will normally invest at least 90% of its net assets (including investment borrowings) in the common stocks and depository receipts that comprise the index. The index is designed to provide exposure to U.S. companies comprising the pharmaceutical sector that have been selected based upon their liquidity and weighted based upon their cumulative score on three investing factors: volatility, value and growth. It is non-diversified.

Main Fund Characteristics

Fund Manager:
First Trust
Asset Under Management:
42,343,400
Launch Date:
19/09/2016
Asset Class:
Equity
Replication Method:
Physical-Full
Number of Holdings:
30
Trading Currency:
USD
Style:
Large Value
Region/Sector/Strategy:
N.A / Healthcare / N.A
Exchange:
NASDAQ

Performance

Period Performance Returns(%) Volatility(%) Risk Adjusted Performance
YTD1.481.231.20
1 Day-0.070.000.00
1 Week1.421.121.27
1 Month6.605.171.28
3 Months5.9211.120.53
6 Months3.0014.830.20
1 Year3.3719.030.18
2 Years10.5323.030.46
3 Years21.5637.390.58
5 Years36.4845.710.80
10 Years0.000.000.00

Price History

-

Annual Performance Return

2012201320142015201620172018201920202021
Price (%) 0.00000.00000.00000.00000.000018.8184-8.358322.351010.87326.1080
Nav (%) 0.00000.00000.00000.00000.00000.00000.00000.00000.00000.0000
Rank 0.00000.00000.00000.00000.000074.000081.000064.000095.000061.0000

Dividend Frequency

Lastest Dividend

Ex Date Payment Date Dividend Payout per unit
22/09/202229/09/20220.0911
23/06/202229/06/20220.0384
24/03/202230/03/20220.0488
22/12/202130/12/20210.1101
22/09/202129/09/20210.0393
23/06/202129/06/20210.0533
24/03/202130/03/20210.0771
23/12/202030/12/20200.0644
24/06/202029/06/20200.0463
25/03/202030/03/20200.0591

Portfolio Data

Total Number of Holdings: 30

Number of Bond Holdings: 0

Number of Equity Holdings: 29

Total Market Value: 42,343,400

Portfolio Composition

Top 10 Holdings

% Portfolio Weight Shares Owned Shares Changed Market Value
1Pfizer Inc8.167339,20401,469,758

Country Exposure

Regional Exposure

America

Greater Europe

Greater Asia

Market Classification

Market Capitalization

Size% of portfolio
Giant33.65
Large23.68
Medium21.72
Small12.37
Micro8.46

Equity Style Box Breakdown

000Large
000Mid
000Small
ValueBlendGrowth

Value Measures

Price/Prospective Earnings*

11.1323

Price/Book*

3.1683

Price/Sales*

1.4043

Price/Cash Flow*

9.0764

Dividend Yield*

2.6389

Growth Measures

Long-Term Earnings

5.1629

Historical Earnings

39.0412

Sales Growth

4.9094

Cash-Flow Growth

2.1162

Book-Value Growth

8.0711

*Forward-looking based on historical data.

Equity Sector

Number of Bond Holdings

0

Bond Statitics

DetailValue
Average Effective Duration0
Average Effective Maturity (Years)*0
Average Credit Quality0
Average Weighted Coupon*0
Average Weighted Price*0

Bond Style Box Breakdown

000HighQuality
000Med
000Low
LtdModExt
Interest-Rate Sensitivity

Credit Quality

Type% Bonds
N.A

Bond Sector

Type
% Bonds

Bond Maturity

% Bonds
N.A

Data Source: Morningstar

© 2019 Morningstar. All Rights Reserved. The information, data, analyses and opinions (“Information”) contained herein:

(1) include the proprietary information of Morningstar and Morningstar’s third party licensors;
(2) may not be copied or redistributed except as specifically authorised;
(3) do not constitute investment advice;
(4) are provided solely for informational purposes;
(5) are not warranted to be complete, accurate or timely; and
(6) may be drawn from fund data published on various dates.

Morningstar and Phillip Securities Pte Ltd are not responsible for any trading decisions, damages or other losses related to the Information or its use. Please verify all of the Information before using it and don’t make any investment decision except upon the advice of a professional financial adviser. Past performance is no guarantee of future results. The value and income derived from investments may go down as well as up.

For the most up-to-date fund’s data and information, a copy of the fund factsheet, information or prospectus may be obtained from the respective ETF issuer.